Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Two Lancaster University researchers have been awarded £125,000 each by the Academy of Medical Sciences.Dr Panagiotis Kotsantis and Dr Stefanie ...

Following favorable phase 1 data showing significant reductions in HBV DNA and RNA, the FDA has fast tracked pevifoscorvir sodium for chronic HBV infection.

Dozens of new discoveries reveal that defenses evolved by bacteria and viruses billions of years ago still define our own ...

Callio Therapeutics is developing novel dual-payload antibody-drug conjugates (ADCs) designed to address resistance to existing cancer therapies, ...

Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.

A high-resolution proteomic landscape of minor glomerular abnormalities (MGAs) is established via pressure cycling technology ...

Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...

Paediatric orbital tumours are rare, and primary orbital lymphomas are particularly uncommon, with an incidence of approximately 0.12 per 1000 000 children. Such lymphomas may present as orbital ...

A massive study of ancient DNA from nearly 16,000 people across more than 10,000 years in West Eurasia reveals that natural ...

In a time when what defines gender is being questioned and discussed, a new study reveals that single changes in DNA make dramatic differences.